ZANEXTRA: An anti-hypertension of a new generation, the successor of Zanidip. The objective was to underline the affiliation with the previous drug but also message the superiority of the new improved version. 

GASTROWELL: An anti-diarrheal and an anti-inflammatory, two versions of the same OTC product. The name had to be simple and easily memorable for both doctors and patients. 

With Zanextra and GastroWell, Quensis fulfills the objective of creating simple, memorable names focused on product or client benefits. Thanks to  innovative technology, Quensis was able to screen names in real time while creating them, against our TM databases and our Drug Name databases.